EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Expression of PAPP ‐A Predicts Poor Outcomes in Oestrogen Receptor‐Positive Breast Cancer Patients

Zeanap Mabruk, Esme Bullock, Xue Xiao iD, Jingjing Guo, Xuan Zhu, Laura Gómez-Cuadrado, Claus Oxvig, Elizabeth Mallon, Aula Ammar iD, Amna Malty, Kathryn Pennel iD, Joanne Edwards iD und 1 weitere

Cancer Medicine · 2026-04 · 15 (4)

DOI: 10.1002/cam4.71815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 13.04.2026. Verfasst von Zeanap Mabruk und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research UK Scotland Centre (Edinburgh), Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Pregnancy-Associated Plasma Protein-A, Breast Neoplasms, Receptors, Estrogen, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Endeavour Scholarship, Sichuan Province Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Insulin‐like growth factor 1 (IGF‐1)/IGF‐1 receptor (IGF‐1R) signalling is activated in breast cancer and associated with disease progression. Pregnancy‐associated plasma protein‐A (PAPP‐A) is a metalloproteinase that can cleave IGF binding proteins leading to the release of bioactive IGF‐1 and the subsequent activation of IGF‐1 signalling. Here, we aimed to assess the prognostic significance of PAPP‐A in breast cancer.

Methods

Breast cancer tissue microarrays were stained for PAPP‐A and expression correlated with survival and other clinical features. Analysis of publicly available data sets was carried out to determine associations between PAPPA and gene sets associated with IGF‐1/IGF‐1R pathway activation.

Results

PAPP‐A was expressed in both the tumour and stromal compartments in breast cancer specimens and was higher in oestrogen receptor (ER)‐negative (ER‐) than ER‐positive (ER+) cases. There was a significant association between high PAPP‐A expression and reduced cancer‐specific survival (CSS) in ER+ (HR 1.389, 95% CI 1.051–1.836, p = 0.021) but not ER‐ patients (HR 1.040, 95% CI 0.712–1.598, p = 0.838). In a second cohort of ER+ invasive lobular carcinoma (ILC) PAPP‐A expression was also associated with reduced CSS (HR 1.765, 95% CI 1.098–2.836, p = 0.019). PAPPA correlated with REACTOME PI3K‐AKT and IGF1R signalling gene sets in ER+ breast cancers.

Conclusion

High expression of PAPP‐A is associated with poor prognosis in ER+ breast cancer and correlates with IGF‐1/IGF‐1R pathway activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy-Associated Plasma Protein-ABreast NeoplasmsReceptors, EstrogenBiomarkers, TumorHumansFemalePrognosisSignal TransductionReceptor, IGF Type 1Middle AgedInsulin-Like Growth Factor IGene Expression Regulation, NeoplasticAdultAged

Stichwörter der Autor:innen

IGF‐1 signallingbreast cancerinvasive lobular carcinomapregnancy‐associated plasma protein‐A

Substanzen

Pregnancy-Associated Plasma Protein-AReceptors, EstrogenReceptor, IGF Type 1PAPPA protein, humanBiomarkers, TumorInsulin-Like Growth Factor IIGF1R protein, human

Autor:innen und Institutionen

  • Cancer Research UK Scotland Centre (Edinburgh), Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, UK.
  • Department of Pathology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Department of Molecular Biology and Genetics, University of Aarhus, Aarhus, Denmark.
  • Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.
  • School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, UK.

ORCID-Profile: Xue Xiao, Aula Ammar, Kathryn Pennel, Joanne Edwards, Valerie G Brunton

Förderung

  • Cancer Research UK
  • Endeavour Scholarship
  • Sichuan Province Science and Technology Support Program
  • Sichuan Provincial People's Hospital
  • Sichuan Provincial Science and Technology Support Program

Zitieren

APA

Mabruk, Z., Bullock, E., Xiao, X., Guo, J., Zhu, X., Gómez-Cuadrado, L., Oxvig, C., Mallon, E., Ammar, A., Malty, A., Pennel, K., Edwards, J., & Brunton, V. G. (2026). High Expression of PAPP ‐A Predicts Poor Outcomes in Oestrogen Receptor‐Positive Breast Cancer Patients. Cancer Medicine, 15(4). https://doi.org/10.1002/cam4.71815

Vancouver

Mabruk Z, Bullock E, Xiao X, Guo J, Zhu X, Gómez-Cuadrado L, et al. High Expression of PAPP ‐A Predicts Poor Outcomes in Oestrogen Receptor‐Positive Breast Cancer Patients. Cancer Medicine. 2026;15(4). doi:10.1002/cam4.71815

BibTeX
@article{Mabruk2026,
  author = {Mabruk, Zeanap and Bullock, Esme and Xiao, Xue and Guo, Jingjing and Zhu, Xuan and Gómez-Cuadrado, Laura and Oxvig, Claus and Mallon, Elizabeth and Ammar, Aula and Malty, Amna and Pennel, Kathryn and Edwards, Joanne and Brunton, Valerie G},
  title = {High Expression of PAPP ‐A Predicts Poor Outcomes in Oestrogen Receptor‐Positive Breast Cancer Patients},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {4},
  doi = {10.1002/cam4.71815}
}
Kostenlos starten →